Regional Account Manager, Complement and Coagulation at Alexion Pharmaceuticals in Milwaukee, WI

Position Summary

The Regional Account Manager (RAM) position is within our Complement Coagulation Franchise, PNH & aHUS, Coagulation a division of Alexion. The RAM will be assigned a sales territory focused on community hospitals, private practices, and infusion centers. Growth and expansion of the Complement and Coagulation portfolio and other products, following FDA approval, for appropriate specialists. The Regional Account Manager is responsible for sales achievement and relationship development across the entire patient journey within aligned accounts and surrounding territory and referral centers in defined area. Products are promoted appropriately an in-serviced throughout assigned community accounts.

Principal Responsibilities

• Consistently achieves or exceeds sales objectives in assigned territory
• Creates and maintains strategically targeted account-specific business plans that reflect an in-depth understanding of local market forces impacting product sales
• Develop and maintain strong in-depth clinical, technical, and scientific knowledge as well as solid marketplace understanding of community accounts placement inside of associated HCO and IDN networks
• Demonstrates the ability to educate on the clinical approach to the disease states leading to a successful differential diagnosis and appropriate testing and treatment of patient population
• Appropriately utilizes all marketing tools and resources including power point presentations
• Collaborate closely with stakeholders, including Complement IAM(s), Coagulation IAM(s), TLL(s), SAL(s), MSL(s) and Market Access, Diagnostics, and enterprise partners
• Leads the implementation for our patient-centric partnership model which will include physicians, their staff, patients, clinics, and hospitals
• Execution of local promotional activities and programs for therapeutics areas
• Provides a high level of product expertise and customer service to all accounts
• Tracks activities and submits reports on sales activities accurately & on-time
• Proactively interacts with Alexion management to refine product and market initiatives
• Work with the highest degree of professionalism and in accordance with the company’s policies and Code of Ethics and Business Conduct

Essential Qualifications

• Bachelor’s Degree
• 6 years Biotechnology/Pharmaceutical sales experience, including 3 years biotechnology/Pharmaceutical sales experience calling on community hospital systems, private practices/clinics
• Proven, documented track record for delivering consistent, 'Top-tier' sales results
• Ability to work effectively independently and in an interdependent, team-oriented environment on a consistent basis
• Demonstrated ability to successfully seek out and qualify leads and profile new accounts
• Ability to gain consistent access & develop strong, professional relationships for scientific exchange and promotion with healthcare providers in community
• Effective administrator who efficiently manages time, CRM tool, resources, and workload
• Effective verbal and written communication skills and organizational abilities
• Ability to travel within territory on a regular basis which will include frequent overnight and weekend travel
• Valid driver's license and clean driving record

Preferred Qualifications

• Advanced or master’s degree
• Sales experience in the orphan or ultra-orphan area

#LI-HT1

,

Some opportunities happen only once in a lifetime – like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders and cardiology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.